Rieko Ohki - Concepedia

Author

Rieko Ohki

The University of Tokyo ORCID

Also Known As

R Ohki, R. Ohki, RIEKO OHKI, Rieko OHKI, Rieko Ohki

Publications

3.9K

Citations

H-Index

Concepts

All Affiliations

The University of Tokyo Tokyo University of Science National Cancer Centre Japan Waseda University Kyoto University

About

Rieko Ohki is an author at The University of Tokyo specializing in medicine, cell biology, and molecular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	13	618
2	Cell Biology	11	11	572
3	Natural Sciences	6	6	327
4	Engineering	1	1	36
5	Biochemistry	1	1	14

Rieko Ohki

Publications

3.8K

Citations

H-Index

Page 1

	Year	Citations
Noxa, a BH3-Only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced Apoptosis Eri Oda, Rieko Ohki, Hideki Murasawa, Science	2000	2.1K
PH Domain-Only Protein PHLDA3 Is a p53-Regulated Repressor of Akt Tatsuya Kawase, Rieko Ohki, Tatsuhiro Shibata, Cell Molecular ResearchP53-regulated RepressorNatural SciencesMolecular BiologyGene Expression	2009	239
Reprimo, a New Candidate Mediator of the p53-mediated Cell Cycle Arrest at the G2 Phase Rieko Ohki, Jiro Nemoto, Hideki Murasawa, Journal of Biological Chemistry	2000	210
Telomere-bound TRF1 and TRF2 stall the replication fork at telomeric repeats Rieko Ohki Nucleic Acids Research	2004	110
PHLDA3 is a novel tumor suppressor of pancreatic neuroendocrine tumors Rieko Ohki, Kozue Saito, Yu Chen, Proceedings of the National Academy of Sciences	2014	103
p53 target gene AEN is a nuclear exonuclease required for p53-dependent apoptosis Tatsuya Kawase, Hitoshi Ichikawa, Tsutomu Ohta, Oncogene P53-dependent ApoptosisNuclear ExonucleaseApoptosisMolecular BiologyCell Death	2008	102
In Vitro Reconstitution of the End Replication Problem Rieko Ohki, Toshiki Tsurimoto, Fuyuki Ishikawa Molecular and Cellular Biology	2001	96
Identification of telomere-associated molecules by engineered DNA-binding molecule-mediated chromatin immunoprecipitation (enChIP) Toshitsugu Fujita, Yoshinori Asano, Junko Ohtsuka, Scientific Reports	2013	93
Intestinal cancer progression by mutant p53 through the acquisition of invasiveness associated with complex glandular formation Mizuho Nakayama, Eri Sakai, Kanae Echizen, Oncogene	2017	76
IER5 generates a novel hypo-phosphorylated active form of HSF1 and contributes to tumorigenesis Yoshinori Asano, Tatsuya Kawase, Atsushi Okabe, Scientific Reports Tumor BiologyTranscriptional RegulationSignaling PathwayMedicineCancer Cell Biology	2016	72

Page 1